Neda A. Moatamed

ORCID: 0000-0002-9986-8058 · 4 papers in corpus
article 2025
·doi:10.1093/ajcp/aqaf121.195

Abstract Introduction/Objective Physiologic changes in the gynecologic tract of transmasculine individuals have been reported in the literature. However, reports of gynecologic pathology in transmasculine individuals are limited. In this ca…

2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00175-w

Progesterone therapy is a viable treatment for complex atypical hyperplasia (CAH) and endometrial adenocarcinoma, though reliable molecular determinants of response are not available. To explore if analysis of pre-therapy endometrial biopsi…

2020
PloS one ·doi:10.1371/journal.pone.0242772

BackgroundIn recent years, sentinel lymph node excision and ultrastaging have been performed in endometrial carcinomas to obtain information about lymph node status, avoiding unnecessary complete pelvic and paraaortic lymphadenectomy. The p…

2018
Case reports in pathology ·doi:10.1155/2018/8148147

BackgroundBRCA gene mutations significantly increase the risk of breast and ovarian cancers where the lifetime risk of the ovarian cancer is about 40%. Therefore, many women with such mutations undergo prophylactic bilateral mastectomy and …